The identification of genetic alterations and variations in RA (involving either the major histocompatibility complex (MHC) or non-MHC genes) and an understanding of their functional consequences may impact the diagnosis, therapy, and prevention of RA [1], an autoimmune disease that affects approximately 1% of the human population. This evidence concerns the gene HLA-C and autoimmune disease.